The Review summarized the recent progress in chemical probes and drug candidates for epigenetic writer enzymes and discussed the implication of targeting the chromatin regulatory landscape in cancer biology and therapy.
- Andrew R. Conery
- Jennifer L. Rocnik
- Patrick Trojer